Artivion Inc (AORT)

Shareholders in Artivion (NYSE:AORT) are in the red if they invested a year ago - Yahoo New Zealand News

Yahoo New Zealand News

Artivion executive sells shares worth over $29k By Investing.com - Investing.com

Investing.com

Artivion executive sells $23,285 in company stock By Investing.com - Investing.com

Investing.com

Artivion executive sells $23,285 in company stock - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Artivion, Inc. (NYSE:AORT) SVP Sells $23,290.41 in Stock - MarketBeat

MarketBeat

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? - Zacks Investment Research

Zacks Investment Research

Stifel Nicolaus Increases Artivion (NYSE:AORT) Price Target to $25.00 - Defense World

Defense World

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

Yahoo Finance

Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher - Simply Wall St

Simply Wall St

Artivion (NYSE:AORT) PT Raised to $30.00 at Needham & Company LLC - Defense World

Defense World

Zurcher Kantonalbank Zurich Cantonalbank Buys 2108 Shares of Artivion, Inc. (NYSE:AORT) - Defense World

Defense World

Artivion stock price target raised on revenue growth - Investing.com Nigeria

Investing.com Nigeria

Artivion (NYSE:AORT) Price Target Increased to $25.00 by Analysts at Stifel Nicolaus - MarketBeat

MarketBeat

Artivion (NYSE:AORT) Reaches New 52-Week High Following Earnings Beat - MarketBeat

MarketBeat

Artivion stock price target raised on revenue growth - Investing.com

Investing.com

Artivion, Inc. (NYSE:AORT) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Artivion, Inc. (NYSE:AORT) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Breaking Down Artivion: 4 Analysts Share Their Views - Artivion (NYSE:AORT) - Benzinga

Benzinga

Artivion: Q1 Earnings Snapshot - Milford Mirror

Milford Mirror

Artivion stock price target raised on revenue growth - Investing.com

Investing.com

Artivion: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Is Artivion (AORT) Outperforming Other Medical Stocks This Year? - Yahoo Canada Shine On

Yahoo Canada Shine On

Artivion Inc (AORT) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance - Yahoo Finance

Yahoo Finance

Artivion (AORT) Tops Q1 Earnings and Revenue Estimates

Zacks Investment Research

Artivion earnings beat by $0.18, revenue topped estimates - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

Artivion (AORT) Tops Q1 Earnings and Revenue Estimates - Zacks Investment Research

Zacks Investment Research

Artivion Reports First Quarter 2024 Financial Results - PR Newswire

PR Newswire

Artivion: Q1 Earnings Snapshot - Houston Chronicle

Houston Chronicle

Artivion presents double win at AATS for aortic devices - Clinical Trials Arena

Clinical Trials Arena

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American ... - Citizentribune

Citizentribune

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American ... - PR Newswire

PR Newswire

Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year - Yahoo

Yahoo

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference - PR Newswire

PR Newswire

Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run?

Zacks Investment Research

Artivion, Inc. (AORT) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Yahoo Finance

Are Medical Stocks Lagging Artivion (AORT) This Year?

Zacks Investment Research

Are Medical Stocks Lagging Artivion (AORT) This Year? - Yahoo

Yahoo

3 Buy-Rated Small Caps Flexing Big Growth

Zacks Investment Research

Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024

Zacks Investment Research

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year? - Yahoo

Yahoo

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference - PR Newswire

PR Newswire

AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?

Zacks Investment Research

Wall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a Bet

Zacks Investment Research

Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday

Benzinga

Artivion (AORT) Surpasses Q4 Earnings and Revenue Estimates

Zacks Investment Research